T. Rowe Price Mid-Cap Growth Fund (RPMGX) is an open-end mutual fund that seeks long-term capital appreciation by investing primarily in a diversified portfolio of common stocks of mid-cap growth companies whose earnings T. Rowe Price expects to grow at a faster rate than the average company; it normally invests at least 80% of its net assets in such securities, with mid-cap companies defined as those within the market capitalization range of either the S&P MidCap 400 Index or the Russell Midcap Growth Index, and may include foreign stocks consistent with its objectives. The fund offers investor shares with a minimum initial investment of $2,500 and an expense ratio of 0.72%, targeting institutional and retail investors focused on mid-cap growth equity exposure. Top holdings as of recent data include Reserve Investment Funds (cash equivalents), Hologic Inc., PTC Inc., Agilent Technologies Inc., Veeva Systems Inc., Hilton Worldwide Holdings Inc., Lattice Semiconductor Corp., Mettler-Toledo International Inc., Yum Brands Inc., and Tyler Technologies Inc., spanning sectors such as healthcare, technology, and consumer cyclical.
Launched on June 30, 1992, the fund is managed by T. Rowe Price Group, Inc., headquartered in Baltimore, Maryland, with primary operations in the United States and potential exposure to foreign markets through its equity investments.
In a significant leadership transition announced in late 2024, longtime lead manager Brian Berghuis, who helmed the fund since its inception and delivered a 12.5% annualized return through February 2025 outperforming the Russell Midcap Growth Index, stepped down as lead manager at the end of September 2025 and retired at year-end; Ashley Woodruff, associate manager since 2020 and named comanager in January 2025, assumed the lead role alongside comanager Don Easley. This change prompted Morningstar to downgrade the fund's People and Process ratings to Above Average from High and place its Medalist Rating under review, amid recent performance challenges in 2024 due to avoidance of high-momentum growth stocks. The fund continues to emphasize fundamental research-driven stock selection within the mid-cap growth segment.